ReviewJournal of Alzheimer's disease reports2019

Biopharmaceutical Monotargeting versus 'Universal Targeting' of Late-Onset Alzheimer's Disease Using Mixtures of Pleiotropic Natural Compounds.

Howard FrielPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.